These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26792986)

  • 21. Frequent hospital readmissions for acute exacerbation of COPD and their associated factors.
    Cao Z; Ong KC; Eng P; Tan WC; Ng TP
    Respirology; 2006 Mar; 11(2):188-95. PubMed ID: 16548905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of Patients With Congestive Heart Failure or Chronic Obstructive Pulmonary Disease Readmissions Within 30 Days Following an Acute Exacerbation.
    Castillo A; Edriss H; Selvan K; Nugent K
    Qual Manag Health Care; 2017; 26(3):152-159. PubMed ID: 28665906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors Associated with Differential Readmission Diagnoses Following Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
    Buhr RG; Jackson NJ; Dubinett SM; Kominski GF; Mangione CM; Ong MK
    J Hosp Med; 2020 Apr; 15(4):219-227. PubMed ID: 32118572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of a home discharge care bundle after acute exacerbation of COPD.
    Cousse S; Gillibert A; Salaün M; Thiberville L; Cuvelier A; Patout M
    Int J Chron Obstruct Pulmon Dis; 2019; 14():289-296. PubMed ID: 30774326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depression Is Associated with Readmission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Iyer AS; Bhatt SP; Garner JJ; Wells JM; Trevor JL; Patel NM; Kirkpatrick d; Williams JC; Dransfield MT
    Ann Am Thorac Soc; 2016 Feb; 13(2):197-203. PubMed ID: 26599286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk assessment and rate of readmission within 30 days of discharge after hospitalization for acute exacerbation of chronic obstructive pulmonary disease.
    Yılmaz C; Özkan S; Erer OF
    Tuberk Toraks; 2021 Sep; 69(3):328-337. PubMed ID: 34581154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors and outcomes associated with chronic obstructive pulmonary disease exacerbations requiring hospitalization.
    Bahadori K; FitzGerald JM; Levy RD; Fera T; Swiston J
    Can Respir J; 2009; 16(4):e43-9. PubMed ID: 19707601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk assessment of readmissions following an initial COPD-related hospitalization.
    Baker CL; Zou KH; Su J
    Int J Chron Obstruct Pulmon Dis; 2013; 8():551-9. PubMed ID: 24348031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of prediction strategy and care coordination for COPD readmissions.
    Bashir B; Schneider D; Naglak MC; Churilla TM; Adelsberger M
    Hosp Pract (1995); 2016 Aug; 44(3):123-8. PubMed ID: 27391991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does pay-for-performance improve patient outcomes in acute exacerbation of COPD admissions?
    Stone PW; Adamson A; Hurst JR; Roberts CM; Quint JK
    Thorax; 2022 Mar; 77(3):239-246. PubMed ID: 34272333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Outcome predictors for COPD patients hospitalized for acute exacerbation].
    Spielmanns M; Axer F; Nell C; Koczulla AR; Boeselt T; Magnet F; Storre JH; Windisch W
    Med Klin Intensivmed Notfmed; 2017 Nov; 112(8):708-716. PubMed ID: 28044184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of the ProPal-COPD tool to identify patients with COPD for proactive palliative care.
    Duenk RG; Verhagen C; Bronkhorst EM; Djamin RS; Bosman GJ; Lammers E; Dekhuijzen P; Vissers K; Engels Y; Heijdra Y
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2121-2128. PubMed ID: 28790815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and economic burden of comorbid coronary artery disease in patients with acute exacerbation of chronic obstructive pulmonary disease: sex differences in a nationwide cohort study.
    Cui Y; Zhan Z; Ma Y; Huang K; Liang C; Mao X; Zhang Y; Ren X; Lei J; Chen Y; Yang T; Wang C
    Respir Res; 2022 Feb; 23(1):28. PubMed ID: 35151338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of a standardized electronic admission order set for acute exacerbation of chronic obstructive pulmonary disease.
    Pendharkar SR; Ospina MB; Southern DA; Hirani N; Graham J; Faris P; Bhutani M; Leigh R; Mody CH; Stickland MK
    BMC Pulm Med; 2018 May; 18(1):93. PubMed ID: 29843772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eosinophils in COPD Exacerbations Are Associated With Increased Readmissions.
    Couillard S; Larivée P; Courteau J; Vanasse A
    Chest; 2017 Feb; 151(2):366-373. PubMed ID: 27746201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for hospital readmission for COPD after implementation of the GOLD guidelines.
    Tsui MS; Lun FC; Cheng LS; Cheung AP; Chan VL; Leung WS; Chu CM
    Int J Tuberc Lung Dis; 2016 Mar; 20(3):396-401. PubMed ID: 27046723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum magnesium is an independent predictor of frequent readmissions due to acute exacerbation of chronic obstructive pulmonary disease.
    Bhatt SP; Khandelwal P; Nanda S; Stoltzfus JC; Fioravanti GT
    Respir Med; 2008 Jul; 102(7):999-1003. PubMed ID: 18396393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time-varying Readmission Diagnoses During 30 Days After Hospitalization for COPD Exacerbation.
    Goto T; Faridi MK; Camargo CA; Hasegawa K
    Med Care; 2018 Aug; 56(8):673-678. PubMed ID: 29912841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Hospital Readmissions Reduction Program and Readmissions for Chronic Obstructive Pulmonary Disease, 2006-2015.
    Myers LC; Faridi MK; Hasegawa K; Hanania NA; Camargo CA
    Ann Am Thorac Soc; 2020 Apr; 17(4):450-456. PubMed ID: 31860333
    [No Abstract]   [Full Text] [Related]  

  • 40. Retrospective audit of antimicrobial prescribing practices for acute exacerbations of chronic obstructive pulmonary diseases in a large regional hospital.
    Brownridge DJ; Zaidi STR
    J Clin Pharm Ther; 2017 Jun; 42(3):301-305. PubMed ID: 28251670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.